IBSA at CPhI Worldwide: innovative products and technologies to develop business opportunities26 October 2021
IBSA will be attending CPhI Worldwide 2021 taking place in Milan from 9th to 11th November. An established name in the pharmaceutical industry, CPhI Worldwide is a highlight on the pharma calendar. It brings together thousands of pharma professionals and suppliers from all over the globe, and providing them with the possibility to connect, develop new business opportunities and discover the latest innovation trends.
During the course of the event, IBSA will be presenting the range of cutting-edge technologies it offers for its main therapeutic areas: Reproductive Medicine, Endocrinology, Pain and Inflammation, Uro-gynaecology, Cardiometabolic, Respiratory, Osteoarticular, Dermatology and Consumer Health.
In particular, the focus will be on ODF technology (orodispersible film), PEARLtec technology for softgel, and on injectable solutions.
The stand will feature a modern lay-out to foster engagement and meetings with potential partners. At IBSA safety and observation of the rules currently in place are of the utmost importance. For this reason, the stand will be carefully organised in keeping with the official guidelines, so as to ensure maximum safety for all involved.
Visitors will have the chance to meet the team of the IBSA Group’s Business Development (BD) department, which is always looking for new partners and international distributors for licensing agreements in countries where IBSA does not already operate directly through its subsidiaries. Indeed, IBSA focuses on strategic collaborations that allow it to achieve common goals, grow at an international level, and expand the product portfolio while sharing responsibilities and resources.
Moreover, thanks to its consolidated experience, its industrial capacity and its proprietary technologies, IBSA is the perfect partner for serving other companies in the pharmaceutical industry on a contract basis, providing services that range from drug development to drug manufacturing for EU and non-EU markets (CDMO).
Those unable to attend the event can submit a form so they can take part virtually and discuss IBSA’s technologies and products.